Table 3 |
|||
|
Essential enzymes and potential chemical inhibitors |
|||
|
Enzyme name |
Potential Inhibitor |
Prior testing? |
Reference |
|
|
|||
|
acetyl-CoA carboxylase |
pseudopeptide pyrrolidine dione antibiotics |
SA, B |
[45] |
|
4-amino-4-deoxychorismate synthase |
(6s)-6-fluoroshikimate |
B |
[46] |
|
Adenosylmethionine decarboxylase |
CGP 40215A, AdoMao |
B |
|
|
asparagine synthase (glutamine-hydrolysing) |
mucochloric and mucobromic acids, L-cysteine sulfinic acid |
B |
|
|
dihydrofolate reductase |
methylpteridines |
B |
[51] |
|
dihydropteroate synthase |
Sulfone and sulfanilamide sulfa drugs |
B |
|
|
3-dehydroquinate synthase |
carbocyclic inhibitors |
B |
[54] |
|
FMN adenylyltransferase (FAD synthase) |
Riboflavin 5'-pyrophosphate |
F |
[55] |
|
glycerol-3-phosphate dehydrogenase (NADP) |
5-n-alk(en)ylresorcinols |
NF |
[56] |
|
glutamine synthetase |
L-methionine sulfoximine, aminomethylene-bisphosphonic acid derivatives |
NF |
|
|
glutamyl-tRNA reductase |
see table I in paper |
NF |
[59] |
|
GTP cyclohydrolase I |
Diamino-6-hydroxypyrimidine, pterins |
NF |
|
|
Hydroxymethylglutaryl CoA reductase (ir) |
statins |
NF |
|
|
Hydroxymethylglutaryl CoA synthase (ir) |
beta-lactone, 3-Hydroxy-3-methylglutaryldithio-coenzyme A |
NF |
|
|
isopentenyl-diphosphate D-isomerase |
NE21650 |
NF |
[66] |
|
methionine adenosyltransferase |
adduncts 14 and 16 |
B |
[67] |
|
Phosphatidate phosphatase |
Propranolol |
NF |
[68] |
|
phosphoribosylpyrophosphate synthetase |
MRPP, ARPP |
NF |
[69] |
|
riboflavin synthase |
9-D-ribitylamino-1,3,7,9-tetrahydro-2,6,8-purinetriones |
B |
[70] |
|
spermidine synthase |
adenosylspermidine, dicyclohexylamine |
SA, B |
|
|
thiamine transport via ABC system |
azidobenzoyl derivatives of thiamin, methylene blue |
F |
|
|
thioredoxin reductase |
Arsenicals, Aurothioglucose |
NF |
|
|
UDP-N-acetylglucosamine 4-epimerase |
uridine analogs |
NF |
[77] |
|
UDP-N-acetylenolpyruvoylglucosamine reductase |
4-thiazolidinones |
B |
[78] |
|
|
|||
|
A reasonable number of enzymes that are computationally predicted to be essential for the growth of S. aureus have inhibitors. These molecules are potential drugs against this organism. The prior testing column uses abbreviations to indicate if we located evidence that the listed compounds had been tested in S. aureus (SA), other bacteria (B), fungi (F), or if no evidence was located (NF). The interested reader should consult the relevant references for full details regarding these potential inhibitors. |
|||
|
Becker and Palsson BMC Microbiology 2005 5:8 doi:10.1186/1471-2180-5-8 |
|||